Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
Patient-derived tumor organoids (PDTOs) represent a significant advancement in cancer research and personalized medicine. These organoids, derived from various cancer types, have shown the ability to retain the genetic and molecular characteristics of the original tumors, allowing for the detailed s...
Saved in:
| Main Authors: | Sebastien Taurin, Reem Alzahrani, Sahar Aloraibi, Layal Ashi, Rawan Alharmi, Noora Hassani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324003528 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in Umbilical Cord Biobanking: A Comprehensive Review of Current Trends and Future Prospects
by: AlOraibi S, et al.
Published: (2024-12-01) -
Bioengineering Tooth and Periodontal Organoids from Stem and Progenitor Cells
by: Fuad Gandhi Torizal, et al.
Published: (2024-10-01) -
Protocol for generating a pancreatic cancer organoid associated with heterogeneous tumor microenvironment
by: Kenta Takeuchi, et al.
Published: (2025-03-01) -
Protocol for cryopreserving neural organoids and human living brain tissue using MEDY
by: Weiwei Xue, et al.
Published: (2024-12-01) -
Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling
by: Weidong Shao, et al.
Published: (2025-01-01)